Tandem Investment Advisors’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-2,383
Closed -$227K 88
2022
Q3
$227K Buy
2,383
+57
+2% +$5.64K 0.01% 77
2022
Q2
$216K Buy
2,326
+119
+5% +$11.6K 0.01% 74
2022
Q1
$223K Sell
2,207
-256
-10% -$26.9K 0.01% 66
2021
Q4
$254K Sell
2,463
-325
-12% -$30K 0.02% 72
2021
Q3
$237K Sell
2,788
-117
-4% -$9.8K 0.02% 66
2021
Q2
$242K Buy
+2,905
New +$238K 0.02% 66
2021
Q1
Sell
-3,340
Closed -$228K 71
2020
Q4
$228K Buy
+3,340
New +$217K 0.02% 69
2019
Q4
Sell
-272,769
Closed -$17.2M 68
2019
Q3
$17.2M Buy
272,769
+252
+0.1% +$14.9K 3.12% 16
2019
Q2
$14.8M Buy
272,517
+23,374
+9% +$1.26M 2.81% 18
2019
Q1
$13.4M Buy
249,143
+37,845
+18% +$2.34M 2.96% 17
2018
Q4
$13.8M Buy
211,298
+12,098
+6% +$903K 3.59% 7
2018
Q3
$15.7M Buy
199,200
+8,889
+5% +$636K 4.3% 4
2018
Q2
$12.2M Buy
190,311
+13,692
+8% +$902K 3.74% 8
2018
Q1
$11M Buy
176,619
+37,582
+27% +$2.7M 3.58% 8
2017
Q4
$10.1M Buy
139,037
+50,634
+57% +$3.68M 3.46% 12
2017
Q3
$7.19M Buy
+88,403
New +$6.99M 2.7% 15

Other funds holding CVS

Tandem Investment Advisors's CVS Position: Q4 2022 in Review

Tandem Investment Advisors sold out of CVS Health (CVS) in Q4 2022, closing a stake of 2,383 shares — an estimated $227K sold.

Tandem Investment Advisors first reported a position in CVS in Q3 2017 and held it in 16 quarters. The position peaked at $17.2M in Q3 2019. 2,405 funds tracked by Wall St. Rank hold CVS as of Q4 2022.

  • Tandem Investment Advisors reported no remaining CVS Health position as of Q4 2022 after selling out during the quarter.
  • Tandem Investment Advisors sold 2,383 CVS Health shares in Q4 2022, an estimated $227K.
  • Tandem Investment Advisors first reported a position in CVS Health in Q3 2017 and held it in 16 quarters.
  • Tandem Investment Advisors's CVS Health position peaked at $17.2M in Q3 2019.
  • 2,405 funds tracked by Wall St. Rank held CVS Health as of Q4 2022.

Based on Tandem Investment Advisors's 13F filing for Q4 2022, filed 6 Feb 2023.